{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:16:22Z","timestamp":1788426982024,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012320","name":"Otto-von-Guericke-Universit\u00e4t Magdeburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012320","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Despite significant advances in melanoma treatment, many survivors continue to experience long-term effects of disease and therapy. Various survivorship care programs have been developed in recent years, but these differ in terms of their scope, content, and delivery. The aim of this scoping review was to summarize existing literature on melanoma survivorship care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The search strategy was developed using the PCC (Population, Concept, Context) framework for scoping reviews. We conducted systematic searches in MEDLINE\u00ae, the Cochrane Library, Web of Science and CINAHL for studies published between 01\/2015 and 03\/2026. Additionally, the reference lists of the included studies were screened. Two researchers conducted the searches independently. They screened the studies using defined criteria and extracted data on study characteristics and the reported care. The results were summarized using the content analysis by Elo and Kyng\u00e4s.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 2,993 references screened, 21 studies met the inclusion criteria and covered seven unique survivorship care programs. These studies were published from 2015 onward. Using the domains of the Cancer survivorship\u00a0care quality\u00a0framework, we characterized the studies as follows: prevention and monitoring of recurrence and new cancers; monitoring and management of physical, psychosocial, and chronic conditions; health promotion and disease prevention; and context-related domains of the healthcare system, such as clinical structure, communication and decision making, and care coordination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This scoping review summarizes the current melanoma survivorship care. Evidence gaps remain, particularly regarding health literacy and health economic perspectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implication for Cancer Survivors<\/jats:title>\n                    <jats:p>The findings will support the development of a patient-centered survivorship care program for people living with and beyond\u00a0melanoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-026-02067-5","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:40:28Z","timestamp":1788424828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survivorship care for melanoma patients: a scoping review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-3022","authenticated-orcid":false,"given":"Madlen","family":"H\u00f6rold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Schutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Philipp","family":"Drewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Haferkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedegund","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"K\u00fcster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Apfelbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3238\/arztebl.m2023.0242","volume":"121","author":"N Eisemann","year":"2024","unstructured":"Eisemann N, Schumann L, Baltus H, Labohm L, Kraywinkel K, Katalinic A. Longer survival from melanoma in Germany. Dtsch Arztebl Int. 2024;121:45\u201351. https:\/\/doi.org\/10.3238\/arztebl.m2023.0242.","journal-title":"Dtsch Arztebl Int"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2407417","volume":"392","author":"JD Wolchok","year":"2025","unstructured":"Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, et al. Final, 10-year outcomes with Nivolumab plus Ipilimumab in advanced melanoma. N Engl J Med. 2025;392:11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa2407417.","journal-title":"N Engl J Med"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/pon.4290","volume":"26","author":"J Dunn","year":"2017","unstructured":"Dunn J, Watson M, Aitken JF, Hyde MK. Systematic review of psychosocial outcomes for patients with advanced melanoma. Psychooncology. 2017;26:1722\u201331. https:\/\/doi.org\/10.1002\/pon.4290.","journal-title":"Psychooncology"},{"key":"2067_CR4","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.ejca.2011.04.029","volume":"47","author":"E Livingstone","year":"2011","unstructured":"Livingstone E, Windemuth-Kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, et al. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer. 2011;47:1977\u201389. https:\/\/doi.org\/10.1016\/j.ejca.2011.04.029.","journal-title":"Eur J Cancer"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/pon.6184","volume":"32","author":"JT Danielsen","year":"2023","unstructured":"Danielsen JT, Str\u00f8m L, Knutzen SM, Schmidt H, Amidi A, Wu LM, et al. Psychological and behavioral symptoms in patients with melanoma: a systematic review and meta-analysis. Psychooncology. 2023;32:1208\u201322. https:\/\/doi.org\/10.1002\/pon.6184.","journal-title":"Psychooncology"},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/bjd.21670","volume":"187","author":"NCW Kamminga","year":"2022","unstructured":"Kamminga NCW, van der Veldt AAM, Joosen MCW, Joode K, Joosse A, Gr\u00fcnhagen DJ, et al. Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma. Br J Dermatol. 2022;187:381\u201391. https:\/\/doi.org\/10.1111\/bjd.21670.","journal-title":"Br J Dermatol"},{"key":"2067_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70039","volume":"131","author":"MA Mollica","year":"2025","unstructured":"Mollica MA, Doose M, Reed C, Tonorezos E. Defining concepts in cancer survivorship. Cancer. 2025;131:e70039. https:\/\/doi.org\/10.1002\/cncr.70039.","journal-title":"Cancer"},{"key":"2067_CR8","volume-title":"From cancer patient to cancer survivor: lost in transition","author":"ME Hewitt","year":"2005","unstructured":"Hewitt ME. From cancer patient to cancer survivor: lost in transition. Washington: National Academies Press; 2005."},{"key":"2067_CR9","unstructured":"National Comprehensive Cancer Network (NCCN). Survivorship Care for Cancer-Related Late and Long-Term Effects. 2024. https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/survivorship-crl-patient.pdf. Accessed 1 Dec 2025."},{"key":"2067_CR10","unstructured":"National Comprehensive Cancer Network (NCCN). Survivorship Care for Healthy Living. 2024. https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/survivorship-hl-patient.pdf. Accessed 1 Dec 2025."},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2024.11.006","volume":"36","author":"T Amaral","year":"2025","unstructured":"Amaral T, Ottaviano M, Arance A, Blank C, Chiarion-Sileni V, Donia M, et al. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36:10\u201330. https:\/\/doi.org\/10.1016\/j.annonc.2024.11.006.","journal-title":"Ann Oncol"},{"key":"2067_CR12","doi-asserted-by":"publisher","unstructured":"Esser P, Mehnert-Theuerkauf A. Cancer-survivorship-care-programme und Selbstmanagement. [Cancer survivorship care programs and self-management]. Onkologe. 2021:1\u20135. https:\/\/doi.org\/10.1007\/s00761-021-00945-4.","DOI":"10.1007\/s00761-021-00945-4"},{"key":"2067_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12312-021-00963-8","volume":"36","author":"K Feldes","year":"2021","unstructured":"Feldes K, Griesshammer E. Europas Kampf gegen Krebs: Europe\u2019s beating cancer plan. Forum. 2021;36:299\u2013304. https:\/\/doi.org\/10.1007\/s12312-021-00963-8.","journal-title":"Forum"},{"key":"2067_CR14","unstructured":"Deutsche Krebsgesellschaft, DKG (German Cancer Society). JANE-2: Joint Action on Networks of Expertise on Cancer. https:\/\/www.krebsgesellschaft.de\/projekte\/jane-2. Accessed 1 Sep 2025"},{"key":"2067_CR15","unstructured":"Deutsche Krebshilfe (German Cancer Aid). Langzeit\u00fcberleben nach Krebs. 2025. https:\/\/www.krebshilfe.de\/forschen\/projekte\/foerderschwerpunkte\/langzeitueberleben-nach-krebs\/. Accessed 1 Sep 2025."},{"key":"2067_CR16","unstructured":"AG LONKO (\u201eLangzeit\u00fcberleben nach Krebs\u201c) im Nationalen Krebsplan Unterarbeitsgruppe \u201eBedarfsgerechte Versorgungsmodelle\u201c (Kurzform: UAG \u201eVersorgungsmodelle\u201c): Empfehlungspapier. 18.06.2021. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/N\/Nationaler_Krebsplan\/Empfehlungspapier_UAG_Versorgungsmodelle_AG_LONKO_bf.pdf. Accessed 23 Nov 2025."},{"key":"2067_CR17","unstructured":"Bundesministerium f\u00fcr Gesundheit. Langzeit\u00fcberleben nach Krebs. 2023. https:\/\/www.bundesgesundheitsministerium.de\/themen\/praevention\/nationaler-krebsplan\/was-haben-wir-bisher-erreicht\/langzeitueberleben-nach-krebs.html. Accessed 18 Apr 2026."},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11912-024-01541-6","volume":"26","author":"J Silverstein","year":"2024","unstructured":"Silverstein J, Goyal N, Tsai KK. For the long haul: management of long-term survivors after melanoma systemic therapy. Curr Oncol Rep. 2024;26:804\u201317. https:\/\/doi.org\/10.1007\/s11912-024-01541-6.","journal-title":"Curr Oncol Rep"},{"key":"2067_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1186\/s12885-025-15326-y","volume":"25","author":"S Bl\u00fctgen","year":"2025","unstructured":"Bl\u00fctgen S, Tigges A-L, Zinkevich A, Krug K, Wensing M, Graf K, et al. \u2018It only works if we coordinate our work, that\u2019s what we need\u2019: a relational qualitative network analysis of exercise therapy in oncology care in Germany. BMC Cancer. 2025;25:1845. https:\/\/doi.org\/10.1186\/s12885-025-15326-y.","journal-title":"BMC Cancer"},{"key":"2067_CR20","unstructured":"Stiftung Deutsche Krebshilfe. Das Netzwerk der Onkologischen Spitzenzentren. 2025. https:\/\/www.ccc-netzwerk.de\/startseite.html. Accessed 9 Apr 2025."},{"key":"2067_CR21","unstructured":"University Cancer Center Hamburg. Survivorship.\u00a0Available from:\u00a0https:\/\/www.uke.de\/english\/departments-institutes\/centers\/university-cancer-center-hamburg-(ucch)%E2%80%94hubertus-wald-tumor-center\/survivorship-program\/index.html. Accessed 26 Feb 2025."},{"key":"2067_CR22","unstructured":"German Cancer Research Center. IMPULS-A: Implementation of a support program for long-term cancer survivors aged 65 and older. 2025."},{"key":"2067_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111572","volume":"176","author":"D Pollock","year":"2024","unstructured":"Pollock D, Evans C, Menghao Jia R, Alexander L, Pieper D, Brand\u00e3o de Moraes \u00c9, et al. \u201cHow-to\u201d: scoping review. J Clin Epidemiol. 2024;176:111572. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111572.","journal-title":"J Clin Epidemiol"},{"key":"2067_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"2067_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/skinhd\/vzag032","author":"M H\u00f6rold","year":"2026","unstructured":"H\u00f6rold M, Drewitz KP, Haferkamp S, Schmitt J, Meier F, P\u00f6schmann L, et al. Living with melanoma: a study protocol for the design and participatory development of a survivorship care program for people with metastatic melanoma. Skin Health Dis. 2026. https:\/\/doi.org\/10.1093\/skinhd\/vzag032.","journal-title":"Skin Health Dis"},{"key":"2067_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"2067_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. https:\/\/doi.org\/10.1136\/bmj.g1687.","journal-title":"BMJ"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.11124\/JBIES-22-00123","volume":"21","author":"D Pollock","year":"2023","unstructured":"Pollock D, Peters MDJ, Khalil H, McInerney P, Alexander L, Tricco AC, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21:520\u201332. https:\/\/doi.org\/10.11124\/JBIES-22-00123.","journal-title":"JBI Evid Synth"},{"key":"2067_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","volume":"62","author":"S Elo","year":"2008","unstructured":"Elo S, Kyng\u00e4s H. The qualitative content analysis process. J Adv Nurs. 2008;62:107\u201315. https:\/\/doi.org\/10.1111\/j.1365-2648.2007.04569.x.","journal-title":"J Adv Nurs"},{"key":"2067_CR30","unstructured":"VERBI Software. Consult. Sozialforschung GmbH. MAXQDA, Software f\u00fcr qualitative Datenanalyse. Berlin; 1989 - 2025."},{"key":"2067_CR31","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/jnci\/djz089","volume":"111","author":"L Nekhlyudov","year":"2019","unstructured":"Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111:1120\u201330. https:\/\/doi.org\/10.1093\/jnci\/djz089.","journal-title":"J Natl Cancer Inst"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1186\/s12885-021-08959-2","volume":"21","author":"F Reilly","year":"2021","unstructured":"Reilly F, Contstable L, Brant W, Rahman K, Durrani A, Burrows N, et al. Achieving integrated self-directed cancer aftercare (ASICA) for melanoma: how a digital intervention to support total skin self-examination was used by people treated for cutaneous melanoma. BMC Cancer. 2021;21:1217. https:\/\/doi.org\/10.1186\/s12885-021-08959-2.","journal-title":"BMC Cancer"},{"key":"2067_CR33","doi-asserted-by":"publisher","DOI":"10.2196\/39544","volume":"6","author":"F Reilly","year":"2023","unstructured":"Reilly F, Wani N, Hall S, Morgan HM, Allan J, Constable L, et al. User experiences in a digital intervention to support total skin self-examination by melanoma survivors: nested qualitative evaluation embedded in a randomized controlled trial. JMIR Dermatol. 2023;6:e39544. https:\/\/doi.org\/10.2196\/39544.","journal-title":"JMIR Dermatol"},{"key":"2067_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007993","volume":"5","author":"P Murchie","year":"2015","unstructured":"Murchie P, Allan JL, Brant W, Dennis M, Hall S, Masthoff J, et al. Total skin self-examination at home for people treated for cutaneous melanoma: development and pilot of a digital intervention. BMJ Open. 2015;5:e007993. https:\/\/doi.org\/10.1136\/bmjopen-2015-007993.","journal-title":"BMJ Open"},{"key":"2067_CR35","doi-asserted-by":"publisher","DOI":"10.2196\/37539","volume":"8","author":"P Murchie","year":"2022","unstructured":"Murchie P, Constable L, Hall S, Brant W, Allan J, Johnston M, et al. The achieving self-directed integrated cancer aftercare intervention for detection of recurrent and second primary melanoma in survivors of melanoma: pilot randomized controlled trial. JMIR Cancer. 2022;8:e37539. https:\/\/doi.org\/10.2196\/37539.","journal-title":"JMIR Cancer"},{"key":"2067_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamadermatol.2021.4704","volume":"158","author":"DM Ackermann","year":"2022","unstructured":"Ackermann DM, Dieng M, Medcalf E, Jenkins MC, van Kemenade CH, Janda M, et al. Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial. JAMA Dermatol. 2022;158:33\u201342. https:\/\/doi.org\/10.1001\/jamadermatol.2021.4704.","journal-title":"JAMA Dermatol"},{"key":"2067_CR37","doi-asserted-by":"publisher","DOI":"10.2196\/40623","volume":"5","author":"D Drabarek","year":"2022","unstructured":"Drabarek D, Habgood E, Ackermann D, Hersch J, Janda M, Morton RL, et al. Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomized controlled trial: qualitative interview study. JMIR Dermatol. 2022;5:e40623. https:\/\/doi.org\/10.2196\/40623.","journal-title":"JMIR Dermatol"},{"key":"2067_CR38","doi-asserted-by":"publisher","first-page":"13758","DOI":"10.1002\/cam4.6012","volume":"12","author":"JR Thompson","year":"2023","unstructured":"Thompson JR, Salam RA, Hanna S, Dieng M, Saw RPM, Bartula I. A systematic review with evidence mapping of supportive care interventions for melanoma patients and caregivers. Cancer Med. 2023;12:13758\u201373. https:\/\/doi.org\/10.1002\/cam4.6012.","journal-title":"Cancer Med"},{"key":"2067_CR39","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1007\/s00520-016-3339-3","volume":"24","author":"NA Kasparian","year":"2016","unstructured":"Kasparian NA, Mireskandari S, Butow PN, Dieng M, Cust AE, Meiser B, et al. Melanoma: questions and answers.\u201d Development and evaluation of a psycho-educational resource for people with a history of melanoma. Support Care Cancer. 2016;24:4849\u201359. https:\/\/doi.org\/10.1007\/s00520-016-3339-3.","journal-title":"Support Care Cancer"},{"key":"2067_CR40","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1200\/JCO.2016.68.2278","volume":"34","author":"M Dieng","year":"2016","unstructured":"Dieng M, Butow PN, Costa DSJ, Morton RL, Menzies SW, Mireskandari S, et al. Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. J Clin Oncol. 2016;34:4405\u201314. https:\/\/doi.org\/10.1200\/JCO.2016.68.2278.","journal-title":"J Clin Oncol"},{"key":"2067_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015195","volume":"7","author":"M Dieng","year":"2017","unstructured":"Dieng M, Kasparian NA, Mireskandari S, Butow P, Costa D, Morton R, et al. Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial. BMJ Open. 2017;7:e015195. https:\/\/doi.org\/10.1136\/bmjopen-2016-015195.","journal-title":"BMJ Open"},{"key":"2067_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-025-01841-1","author":"SM Hansen","year":"2025","unstructured":"Hansen SM, Johansen C, Kasparian NA, Grand MK, Bidstrup PE, H\u00f6lmich LR. Employing skin self-examination and fear of cancer recurrence management in early-stage melanoma follow-up: evaluation of the MELACARE intervention in a randomised controlled trial. J Cancer Surviv. 2025. https:\/\/doi.org\/10.1007\/s11764-025-01841-1.","journal-title":"J Cancer Surviv"},{"key":"2067_CR43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2340\/1651-226X.2024.41037","volume":"63","author":"SM Hansen","year":"2024","unstructured":"Hansen SM, Johansen C, Obinah MPB, Kasparian NA, Genter P, Bidstrup PE, et al. MELACARE Nurse-led follow-up after early-stage melanoma: protocol and feasibility. Acta Oncol. 2024;63:909\u201314. https:\/\/doi.org\/10.2340\/1651-226X.2024.41037.","journal-title":"Acta Oncol"},{"key":"2067_CR44","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1007\/s00520-022-07360-4","volume":"30","author":"J Lai-Kwon","year":"2022","unstructured":"Lai-Kwon J, Kelly B, Lane S, Biviano R, Bartula I, Brennan F, et al. Feasibility, acceptability, and utility of a nurse-led survivorship program for people with metastatic melanoma (MELCARE). Support Care Cancer. 2022;30:9587\u201396. https:\/\/doi.org\/10.1007\/s00520-022-07360-4.","journal-title":"Support Care Cancer"},{"key":"2067_CR45","doi-asserted-by":"publisher","first-page":"e58938","DOI":"10.2196\/58938","volume":"11","author":"I Fraterman","year":"2025","unstructured":"Fraterman I, Sacchi L, Mallo H, Tibollo V, Glaser SLC, Medlock S, et al. Exploring the impact of the multimodal CAPABLE eHealth intervention on health-related quality of life in patients with melanoma undergoing immune-checkpoint inhibition: prospective pilot study. JMIR Cancer. 2025;11:e58938. https:\/\/doi.org\/10.2196\/58938.","journal-title":"JMIR Cancer"},{"key":"2067_CR46","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1186\/s12885-022-10253-8","volume":"22","author":"M Zi\u0119tek","year":"2022","unstructured":"Zi\u0119tek M, Wierzbicki J, Pawlak E, Maciejczyk A, Matkowski R. Introduction of a pilot program to measure and improve the clinical care of melanoma patients in the Lower Silesian Voivodeship in Poland: a report of 20 months experience. BMC Cancer. 2022;22:1207. https:\/\/doi.org\/10.1186\/s12885-022-10253-8.","journal-title":"BMC Cancer"},{"key":"2067_CR47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.5114\/ada.2025.158233","volume":"42","author":"M Zi\u0119tek","year":"2025","unstructured":"Zi\u0119tek M, Nowacki M, Wierzbicki J, Nowacka K, Madej I, Pawlak E, et al. Assessing melanoma patients\u2019 satisfaction with treatment and clinical care: preliminary findings from a novel regional pilot program. Postepy Dermatol Alergol. 2025;42:599\u2013605. https:\/\/doi.org\/10.5114\/ada.2025.158233.","journal-title":"Postepy Dermatol Alergol"},{"key":"2067_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12885-023-10759-9","volume":"23","author":"NCW Kamminga","year":"2023","unstructured":"Kamminga NCW, Wakkee M, de Bruin RJ, van der Veldt AAM, Joosse A, Reeder SWI, et al. Oncological healthcare providers\u2019 perspectives on appropriate melanoma survivorship care: a qualitative focus group study. BMC Cancer. 2023;23:278. https:\/\/doi.org\/10.1186\/s12885-023-10759-9.","journal-title":"BMC Cancer"},{"key":"2067_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/17538157.2025.2606849","author":"R Nopour","year":"2026","unstructured":"Nopour R. Effectiveness of telemedicine interventions in the care management of melanoma: a systematic review. Inform Health Soc Care. 2026. https:\/\/doi.org\/10.1080\/17538157.2025.2606849.","journal-title":"Inform Health Soc Care"},{"key":"2067_CR50","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00520-018-4574-6","volume":"27","author":"L Russell","year":"2019","unstructured":"Russell L, Ugalde A, Orellana L, Milne D, Krishnasamy M, Chambers R, et al. A pilot randomised controlled trial of an online mindfulness-based program for people diagnosed with melanoma. Support Care Cancer. 2019;27:2735\u201346. https:\/\/doi.org\/10.1007\/s00520-018-4574-6.","journal-title":"Support Care Cancer"},{"key":"2067_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/13674676.2011.562492","volume":"15","author":"BS Cole","year":"2012","unstructured":"Cole BS, Hopkins CM, Spiegel J, Tisak J, Agarwala S, Kirkwood JM. A randomised clinical trial of the effects of spiritually focused meditation for people with metastatic melanoma. Ment Health Relig Cult. 2012;15:161\u201374. https:\/\/doi.org\/10.1080\/13674676.2011.562492.","journal-title":"Ment Health Relig Cult"},{"key":"2067_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1207\/S15327027HC1303_4","volume":"13","author":"RR Rudy","year":"2001","unstructured":"Rudy RR, Rosenfeld LB, Galassi JP, Parker J, Schanberg R. Participants\u2019 perceptions of a peer-helper, telephone-based social support intervention for melanoma patients. Health Commun. 2001;13:285\u2013305. https:\/\/doi.org\/10.1207\/S15327027HC1303_4.","journal-title":"Health Commun"},{"key":"2067_CR53","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F.\u00a0Global Cancer Observatory: Cancer Today (2022 estimates, version 1.2). Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today\/en. Accessed 29 Sept 2025"},{"key":"2067_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/ijerph21020122","volume":"21","author":"M Torreggiani","year":"2024","unstructured":"Torreggiani M, Maselli D, Costi S, Guberti M. Models of care in providing comprehensive healthcare on cancer survivors: a scoping review with a TIDieR checklist analysis. Int J Environ Res Public Health. 2024;21:122. https:\/\/doi.org\/10.3390\/ijerph21020122.","journal-title":"Int J Environ Res Public Health"},{"key":"2067_CR55","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00103-022-03514-1","volume":"65","author":"A Mehnert-Theuerkauf","year":"2022","unstructured":"Mehnert-Theuerkauf A, Esser P. Survivorship-Care-Programme f\u00fcr Krebspatienten: die Bedeutung von Risikostratifizierung, Selbstmanagement- und Gesundheitskompetenzen im Zeitalter digitaler Versorgung. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2022;65:412\u20139. https:\/\/doi.org\/10.1007\/s00103-022-03514-1.","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-026-02067-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02067-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:40:30Z","timestamp":1788424830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-026-02067-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":55,"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1007\/s11764-026-02067-5","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Schmitt reports institutional grants for investigator-initiated research from the German Federal Joint Committee, German Ministry of Health, German Ministry of Research, European Union, German Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK\u201d All other authors declare that they have no competing interests that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}